Tauro, Sudhir

Dr

  • United Kingdom

  • 4461 Citations
  • 16 h-Index
20012019
If you made any changes in Pure these will be visible here soon.

Research Output 2001 2019

Filter
Letter
2016
13 Citations (Scopus)
95 Downloads (Pure)

Cytopenia levels for aiding establishment of the diagnosis of Myelodysplastic Syndromes

Greenberg, P. L., Tuechler, H., Schanz, J., Sanz, G., Garcia-Manero, G., Solé, F., Bennett, J. M., Bowen, D., Fenaux, P., Dreyfus, F., Kantarjian, H., Kuendgen, A., Levis, A., Malcovati, L., Cazzola, M., Cermak, J., Fonatsch, C., Le Beau, M. M., Slovak, M. L., Krieger, O. & 14 others, Luebbert, M., Maciejewski, J., Magalhaes, S. M. M., Miyazaki, Y., Pfeilstocker, M., Sekeres, M., Sperr, W. R., Stauder, R., Tauro, S., Valent, P., Vallespi, T., Van De Loosdrecht, A. A., Germing, U. & Haase, D., 20 Oct 2016, In : Blood. 128, 16, p. 2096-2097 5 p.

Research output: Contribution to journalLetter

Open Access
File
2013
4 Citations (Scopus)

Azacitidine-eligibility in higher-risk myelodysplastic syndromes and chronic myelomonocytic leukaemia: A registry-based study

Durairaj, S., Keenan, N., Hyslop, A., Groves, M. J., Bowen, D. T. & Tauro, S., Apr 2013, In : British Journal of Haematology. 161, 2, p. 280-282 3 p.

Research output: Contribution to journalLetter

2010
3 Citations (Scopus)

Immunohistochemical localization of cellular NFATc1 does not predict clinical responses to ciclosporin in subcutaneous panniculitis-like T-cell non-Hodgkin lymphoma

Tauro, S., MacCallum, S., Groves, M. J., Rojnuckarin, P., Assanasen, T., Feldman, A. L., Robson, A., Marschalko, M., Kini, H., Alzolibani, A. A., Al Robaee, A., Al Shobaili, H. A., Alfawzan, S., Goodlad, J. R., Kernohan, N., Hummel, M., Sterry, W. & Assaf, C., Apr 2010, In : British Journal of Dermatology. 162, 4, p. 887-889 3 p.

Research output: Contribution to journalLetter

2009
1 Citation (Scopus)

The annexin-V assay reflects susceptibility to in vitro membrane damage in chronic lymphocytic leukemia and may overestimate cell death

Groves, M. J., MacCallum, S., Boylan, M. T., Coates, P. J. & Tauro, S., Mar 2009, In : American Journal of Hematology. 84, 3, p. 196-197 2 p.

Research output: Contribution to journalLetter

2008
7 Citations (Scopus)

Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia

Tholouli, E., Liakopoulou, E., Greenfield, H. M., Shaw, B. E., Tauro, S., Byrne, J. L., Dennis, M., Burthem, J., Lucas, G. S., Craddock, C., Russell, N. H. & Yin, J. A. L., Jul 2008, In : British Journal of Haematology. 142, 2, p. 318-320 3 p.

Research output: Contribution to journalLetter

Sequential tyrosine kinase inhibitor therapy: sustained disease remission in Philadelphia-positive erythroleukaemia

Craig, J., Walker, K., Sales, M., Cunningham, J., Gelly, K., Pippard, M. J. & Tauro, S., Aug 2008, In : British Journal of Haematology. 142, 4, p. 674-675 2 p.

Research output: Contribution to journalLetter

2002

Response to Dr SD Mundle

Tauro, S., Hepburn, M., Peddie, C., Bowen, D. & Pippard, M., May 2002, In : Leukemia. 16, 5, p. 961 1 p.

Research output: Contribution to journalLetter